Viewing Study NCT05549557


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2025-12-25 @ 4:35 PM
Study NCT ID: NCT05549557
Status: UNKNOWN
Last Update Posted: 2022-09-22
First Post: 2022-09-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: IMM40H Phase I Dose Escalation and Expansion
Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module